HIV and AIDS Global: 40M HIV positive 25M AIDS deaths from ‘80 (60% sub-Saharan Africa) 80+% male Canada:63K HIV positive 16K AIDS deaths since 1980 (83%

Slides:



Advertisements
Similar presentations
HIV and its lifecycle Sources: Wikipedia, HIV is a retrovirus (enveloped viruses possessing an RNA genome,
Advertisements

Slide #1 HIV Entry Inhibitors Trip Gulick, MD, MPH Director, Cornell HIV Clinical Trials Unit Associate Professor of Medicine Weill Medical College of.
D7 - Antivirals. D.7.1 State how viruses differ from bacteria.
Treating HIV with Azidothymidine (AZT) A Design by Jeanine Nasser.
Treatment of AIDS “Antiretroviral therapy & vaccines”
1 Antiviral Drugs Limited selective toxicity –Viruses mostly use host cell machinery, so very few unique targets –Most drugs block steps that take place.
Antivirals Slackers Facts by Mike Ori. Disclaimer The information represents my understanding only so errors and omissions are probably rampant. It has.
HIV and AIDS Human Immunodeficiency Virus (HIV) is the virus that causes Acquired Immunodeficiency Syndrome (AIDS).
Dr. Abdulkarim Alhethail
Vaccines and Antivirals. Clinical Use of Interferon Therefore they have been used in the treatment of cancers of various types. Therefore they have been.
Lecture 29: Viruses 0.5 m.
HIV Structure, Lifecycle, and Replication
Antiviral Agents, chapter 39 Different living organisms.
ANTIRETROVIRAL RESISTANCE Jennifer Fulcher, MD, PhD.
1. What is the most common mode of HIV transmission? 2. How else is HIV transmitted? 3. What is the most common mode of work related transmission? p.
Chemistry: An Introduction to General, Organic, and Biological Chemistry, Eleventh Edition Copyright © 2012 by Pearson Education, Inc. Chapter 17 Nucleic.
D7 - Antivirals Differences between bacteria and viruses How does antiviral drugs work? The AIDS problem.
AIDS L2 Biology.
Viruses& Human Health ‏ Human Health ‏ June 23, 20091SBI3C.
HIV, CD4, and More Karen Hutcherson Jenn Mann Elizabeth McCauley Michael Powers Courtney Wilson.
Plate 87 Acquired Immune Deficiency Syndrome (AIDS)
AIDS supplement. History of HIV Originated in Africa in the late 1950’s Originally found in nonhuman primates and may have mutated First documented in.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 93 Antiviral Agents II: Drugs for HIV Infection and Related.
Antiviral Agents Restricted spectrum
Acquired Immunodeficiency Syndrome (AIDS). History u 1950s: Blood samples from Africa have HIV antibodies. u 1976: First known AIDS patient died. u 1980:
Chapter 17: HIV/AIDS. HIV/AIDS -HIV: Human Immunodeficiency Virus -AIDS: Acquired Immunodeficiency Syndrome -AIDS represents the end stage of infection.
By: Lana & Layal Abuhamdeh. VIRUSES  Viruses are much smaller than bacteria  Many different types of virus, vary in shape and structure  All viruses.
Virsuses: Human Immunodeficiency Syndrome & Acquired Immunodeficiency Syndrome.
Is HIV and AIDS the same thing? HIV “Human Immunodeficiency Syndrome” A specific type of virus (a retrovirus) HIV invades the helper T cells to replicate.
1 Introduction to ARV Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Antiviral Drugs: An Overview Prof. Sri Agus Sudjarwo.,Ph.D.
VIRUSES NONLIVING PARTICLES. Viruses  Smaller than bacteria  Known since late 1800’s but no way to study them  1935 Tobacco mosaic virus was crystallized.
HIV & AIDS BY DR. MOHAMMED ARIF HEAD OF THE VIROLOGY UNIT ASSOCIATE PROFESSOR & CONSULTANT VIROLOGIST.
Antivirals. Structure of a Virus all viruses- o have a central core of DNA or RNA o surrounded by a coat(capsid) of packed protein units(capsomers) UNLIKE.
Chapter 10 An Evolving Enemy Silvio Penta Silvio Penta Christie DiDonato Christie DiDonato Carl Tuoni Carl Tuoni Beth Miller Beth Miller.
HIV-1 dynamics Perelson et.al. Science 271:1582 (1996) Infected CD4 + lymphocytes Uninfected, activated CD4 + lymphocytes HIV-1 t 1/ days t 1/2.
Medicines and Drugs Anti-virals Julia Barnes Anna Cruickshank.
Anti-viral Drugs.. Introduction The viral agents kill viruses by inhibiting their ability to replicate, but there are currently only about a dozen such.
The Life and Times of Anitvirals By: Karen Summers Louise Pilsbury Jasmine Delaine Irfan Mekic Bethannie Jamerson.
Medicines and drugs antivirals.
Highly Active Antiretroviral Therapy (HAART) Cocktail Therapy
HIV Life Cycle Step 1: Fusion Step 2: Transcription reverse transcriptase Step 3: Integration Step 4: Cleavage Step 5: Packaging and Budding HIV.
Virsuses: Human Immunodeficiency Syndrome & Acquired Immunodeficiency Syndrome.
Antiretroviral targets in the viral life cycle Viral Replication and Drug targets.
Viruses Chapter What is a virus? Viruses- microscopic particles that invade cells and destroy them. A virus is NOT a cell. Has genetic material.
Antiviral drugs.
Basics of Human Immunodeficiency Virus (HIV) Brian Rybarczyk, PhD University of North Carolina- Chapel Hill.
The HIV virus. Objectives At the end of this session the participants will be able to: 1. Understand basic HIV structure 2. Describe the significance.
ANTIVIRAL THERAPY DR FATAI OLUYADI USMLEINCLINED.COM 1.
General, Organic, and Biological Chemistry Copyright © 2010 Pearson Education, Inc Viruses Chapter 21 Nucleic Acids and Protein Synthesis.
Virology – Antivirals 2 JU- 2 nd Year Medical Students By Dr Hamed AlZoubi – Microbiology and Immunology Department – Mutah University. MBBS (J.U.S.T)
HIV VIRUS. HIV stands for Human Immunodeficiency Virus. IT is a lentivirus. (a member of the retrovirus family) HIV is the virus that causes AIDS. (Acquired.
Viral Structure, Lifecycles, HIV, and the Immune System.
VIRUSES and THEIR RELATIVES VIRUSES and THEIR RELATIVES.
Chapter 2: The Path from HIV to AIDS
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 94 Antiviral Agents II: Drugs for HIV Infection and.
Create a concept map of the adaptive immune system.
Antivirals Essential idea
Enzyme Inhibition in the Treatment of AIDS
Antiretroviral Therapy (ART)
Antiviral Drugs.
AIDS supplement.
HIV/AIDS By: Khatiga Shervani , Karla Molina, Tiffany Cordero, and Claribel Torres Ms. Green and Ms. Geshke Period 3.
Antivirals Essential idea
AIM: How does HIV cause someone to get sick?
Human Health and Disease
Chapter 17a HIV infection and AIDS.
Antiviral Agents.
School of Pharmacy, University of Nizwa
Chapter 18. Viral Genetics
Presentation transcript:

HIV and AIDS Global: 40M HIV positive 25M AIDS deaths from ‘80 (60% sub-Saharan Africa) 80+% male Canada:63K HIV positive 16K AIDS deaths since 1980 (83% male) BC:13K HIV positive 3K AIDS deaths since 1980

AIDS and HIV Cases in Canada over the past 30 years

THE HIV VIRUS Disease discovered in 1981; virus discovered 1983 RETROVIRUS – Normally DNA is used to form RNA in the host cell In HIV, RNA forms DNA in the host cell It is a cell parasite, can only live in a cell, uses host material to reproduce It is a piece of RNA packaged in a protein with a fatty envelope. It attacks our T4 cells, preventing defense against other viruses, bacteria

Symptoms: fever, cough, headache, sweats In 6-12 weeks blood tests +ve for HIV Disease (AIDS) can switch on at any time: swollen lymph nodes, tiredness, loss of weight, abdominal discomfort, diarrhea, fevers, itching, attack by opportunistic infections (pneumonia is most common in Canada) TREATMENT Three main types 1) REVERSE TRANSCRIPTASE INHIBITORS 2) PROTEASE INHIBITORS 3) ENTRY INHIBITORS coming now: Integration inhibitors and Maturation inhibitors

1) REVERSE TRANSCRIPTASE INHIBITORS RNA/DNA Made of Nucleotides:

These provide the templates for making proteins (we will see this in detail under proteins): each set of 3-bases provides a template or code for a single amino-acid in a protein so if the virus can be tricked by feeding useless mimics of these nucleotides, it might produce a useless protein or not even produce one prevents the virus from building new DNA from its RNA, and they are thus called REVERSE TRANSCRIPTASE INHIBITORS

AZTDDI DDC mimics: thymidine guanosine cytidine AzidothymidineDideoxyinosine Dideoxycytidine [zidovudine, Retrovir] [didanosine, Videx] [zalcitabine, Hivid] 5 x 100mg 2 x 200mg 3 x 0.7 mg /day cocktails work better: eg mg DDC mg AZT every 8 h

AZT was first made in 60's as an anti-cancer drug (same mechanism) but it did not work BUT it does work for the HIV virus Approved in 1987: Burroughs-Welcome stock rose $3B overnight! DOSE then was 1.2 g/day ($8000/yr), now about 500 mg/day (at the same cost!)

AZT SIDE EFFECTS: supressed bone marrow production, low white cell counts, anaemia, nausea, headaches, muscle wasting DDI is less active BUT less toxic, so less side effects: peripheral nerve damage - feet tingle (About 40% cannot tolerate AZT) In Canada: didanosine (DDI), lamivudine (3TC); stavudine (d4T), zalcitabine (DDC) zidovudine (AZT) 3TC = Heptovir = 3-thia( )-dideoxycytidine d4T = Zerit = 3-deoxy-thymidine-ene ( )

ACYCLOVIR [ZOVIRAX] HERPES VIRUS INHIBITOR for HIV, AZT + ZOVIRAX works better than AZT alone For herpes (lips or genitals): cream (50 mg/g) or oral: 200 mg/4 h (5x per day) for 10 days Herpes: famciclovir, valacyclovir, valganciclovir, ribavirin

2) PROTEASE INHIBITORS: Inhibit the enzyme that cleaves the viral large proteins in to new ones used for assembly atazanivir fosamprenavir lopinavir darunavir

Use about 800mg every 8 h; $10-15,000/y Most cocktails knock down the virus levels rapidly in 1 st two weeks, more slowly after that Cannot stop drugs, even for one day! Cocktails have advantage of reducing resistance. Relenza (zanamivir), and Tamiflu (oseltamavir) for FLU are also protease inhibitors (not effective against H5N1):

3) ENTRY (FUSION) INHIBITORS Glycoproteins on virus (GP41 and GP120) bind to surface protein receptors (CD4 and CCR5) on T-cell facilitating cell fusion and virus entry

Enfurvitide: 36-peptide chain that binds to GP41 and prevents it binding to CCR5 Approved drugs in this class Maraviroc (Selzentry) by Pfizer: binds directly to CCR5 and blocks fusion appears quite safe for long term use

Maturation Inhibitor: disrupts protein protecting virus core Virus budding inhibitors –yet to come Integration Inhibitor: stops integration of viral dna into host cell’s dna to replicate virus – not in other cells raltegravir (Isentress) from Merck approved FDA Oct 07 Other strategies being explored